Puretech Ventures, Boston, Massachusetts 02116, USA.
Nat Rev Drug Discov. 2011 Aug 1;10(8):559-60. doi: 10.1038/nrd3514.
Mergers and acquisitions in the pharmaceutical industry have substantially reduced the number of major companies over the past 15 years. The short-term business rationale for this extensive consolidation might have been reasonable, but at what cost to research and development productivity?
在过去的 15 年中，制药行业的并购大大减少了主要公司的数量。这种广泛整合的短期商业理由可能是合理的，但对研发生产力造成了什么代价？
